No. I think they are estimating early 2017. Send John an email, unlike another company we know, he is very responsive. John D. Menditto Vice President, Corporate Communications and Investor Relations Argos Therapeutics, Inc. (NASDAQ: ARGS) O: 919.908.0687 M: 732.614.9041 E: jmenditto@argostherapeutics.com Argos_RGB.png